MONTERIS MEDICAL HOLDINGS, INC

Plymouth, MN · Founded 2006 · Medtech · Private

NeuroBlate, a laser interstitial thermal therapy (LITT) platform for minimally invasive ablation of brain tumors, radiation necrosis, and drug-resistant epilepsy

Claim this profile

Follows are private to you and power your alerts

Updated · monteris.com

Sector
Medtech
Headquarters
Plymouth, MN
Founded
2006
Latest Form D
$3.7M, Oct 2013
Total capital
$9M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$9M
3 Form D · last Oct 2013
156 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20092010201120122013FEDERAL ↑EQUITY ↓Cumulative $9M1st Form D$2M2nd Form D$3.4M3rd Form D$3.7M
20092010201120122013FEDERAL ↑EQUITY ↓Cumulative $9M2nd Form D$3.4M3rd Form D$3.7M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$3.7M
  • Private capital raisedForm D · SEC · 2nd filing$3.4M
  • Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Daniel ColeDirectorNamed in SEC Form D filings
  • Gary BantleDirectorNamed in SEC Form D filings
  • Gregory BarrettDirectorNamed in SEC Form D filings
  • James RichardsonDirectorNamed in SEC Form D filings
  • John SchellhornExecutive Officer, DirectorNamed in SEC Form D filings
  • Kevin McGarryDirectorNamed in SEC Form D filings
Show all 8 people
  • Patrick MorandDirectorNamed in SEC Form D filings
  • Robert K DavidsonExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • OXYBAND TECHNOLOGIES INCSimilar federal contract value in Medtech · null in contracts
  • PERCEPTRON HEALTH, INC.Similar federal contract value in Medtech · null in contracts
  • DropletPharm Inc.Similar federal contract value in Medtech · null in contracts
  • NOTA Laboratories, Inc.Similar federal contract value in Medtech · null in contracts
  • L37, LLCSimilar federal contract value in Medtech · null in contracts
  • Noxilizer IncSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .